Valuation Roche Holding AG London S.E.

Stocks

Real-time Estimate Cboe Europe Other stock markets 08:54:49 2026-06-18 EDT			5-day change	1st Jan Change
322.65 ^CHF	-0.39%		0.00%	-1.29%

02:21am	Roche Receives FDA Acceptance for Supplemental Biologics License Application For Lunsumio And Polivy Combination For Relapsed Or Refractory Large B-Cell Lymphoma	CI
02:17am	Warsh of the Worlds

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	306,810	239,812	197,073	205,191	262,098	261,358	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	-0.28%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	271,792	265,114	257,425
Change	-	-21.41%	-15.51%	3.13%	25.04%	-2.32%	-2.46%	-2.9%
P/E	23.4x	18.9x	17.1x	24.8x	20.5x	17.5x	16.3x	15.1x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	6.49x	5.48x	4.66x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1x	2.36x	1.78x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.18x	4.02x	3.83x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.34x	4.08x	3.77x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	10.7x	9.77x	8.95x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	12.1x	11x	10x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	17.5x	16.2x	14.6x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.71%	6.17%	6.86%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.01	10.25	10.52
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	3.05%	3.13%	3.21%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.77	20.06	21.76
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	53.4%	51.1%	48.4%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,557	65,058	68,207
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,443	27,124	28,764
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,547	24,140	25,685
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,225	16,245	17,443
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,433	3,756	-3,933
Reference price ²	379.10	290.50	244.50	255.50	328.20	327.80	327.80	327.80
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	2/3/22	2/2/23	2/1/24	1/30/25	1/29/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.54x	11.83x	24.36x	0.61%	992B
JOHNSON & JOHNSON	25.03x	5.77x	15.69x	2.28%	564B
ABBVIE INC.	27.45x	6.62x	13.53x	3.1%	391B
ASTRAZENECA PLC	22.62x	4.72x	13.39x	1.85%	280B
NOVARTIS AG	21.12x	5.46x	13.25x	2.94%	279B
NOVO NORDISK A/S	12.67x	4.72x	9.72x	3.98%	196B
AMGEN INC.	22.21x	5.97x	10.43x	2.95%	184B
GILEAD SCIENCES, INC.	-44.95x	5.42x	29.92x	2.59%	156B
PFIZER INC.	12.12x	3.18x	7.73x	6.76%	148B
Average	14.53x	5.97x	15.34x	3.01%	354.38B
Weighted average by Cap.	22.17x	7.45x	17.36x	2.25%